D’amico et al. previously showed that targeting CNBP or ODC1 impairs SHH-driven medulloblastoma and inferred that the SHH/AMPK/CNBP axis may be pro-tumorigenic in this context [34]. The gene discussed is PRKAA2; the disease is medulloblastoma.